{"page":{"totalFilteredElements":381},"studies":[{"active":true,"description":"A phase 2b, randomized, blinded, placebo-controlled trial investigating the efficacy of visugromab plus nivolumab in combination with docetaxel versus docetaxel alone in metastatic non-squamous non-small-cell lung cancer (nsq-NSCLC) after failing one prior line of systemic treatment containing a checkpoint inhibitor for advanced/metastatic nsq-NSCLC","eudractNumber":"2024-516794-70","id":10165,"indications":[{"id":"lun","name":"Lungentumoren"},{"id":"lun2","name":"Nicht-kleinzelliges Bronchialkarzinom (NSCLC)"},{"id":"lym","name":"Lymphome inkl. Morbus Hodgkin, Multiples Myelom und Chronisch Lymphatischer Leukämie (CLL)"},{"id":"lym4","name":"Weitere"}],"mutations":[],"nctNumber":"NCT07246863","phase":{"id":"ph_16","name":"IIB"},"recruitmentStart":"2026-02-24T09:19:02+01:00","shortTitle":"Catalym CTL-002-004 GDFATHER-LUNG-02","therapeutical":true,"therapyLines":[{"id":"tl_2","name":"Zweitlinie"},{"id":"tl_9","name":"Metastatic"}]},{"active":true,"description":"Multicenter, single arm, prospective, oben-label, observational PCMF Study&#160;<div>The performance/Safety of Celsite venous access ports in patients who need repeated venous access&#160;<div>Braun Study Identification No: AAG-0-H-2122 ACRONYM: CAP</div></div>","eudractNumber":null,"id":11515,"indications":[{"id":"lym","name":"Lymphome inkl. Morbus Hodgkin, Multiples Myelom und Chronisch Lymphatischer Leukämie (CLL)"},{"id":"lym4","name":"Weitere"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_2","name":"Anwendungsbeobachtung"},"recruitmentStart":"2024-11-27T08:47:15+01:00","shortTitle":"Celsite PMCF_Radiologie","therapeutical":false,"therapyLines":[]},{"active":true,"description":"Charakterisierung\ndes Signalnetzwerkes und der Mikroumgebung in Plasmazelldyskrasien","eudractNumber":null,"id":11386,"indications":[{"id":"lym","name":"Lymphome inkl. Morbus Hodgkin, Multiples Myelom und Chronisch Lymphatischer Leukämie (CLL)"},{"id":"lym1","name":"Plasmozytom (Multiples Myelom)"},{"id":"lym3","name":"Non-Hodgkin Lymphome (inkl. Chron. Lymphat. Leukämie, CLL)"},{"id":"lym4","name":"Weitere"}],"mutations":[],"nctNumber":null,"phase":null,"recruitmentStart":"2025-02-01T09:04:26+01:00","shortTitle":"Charakterisierung des Signalnetzwerkes und der Mikroumgebung in Plasmazelldyskrasien","therapeutical":false,"therapyLines":[]},{"active":true,"description":"Charakterisierung des onkogenen \nSignalnetzwerkes im Multiplen Myelom: Entwicklung neuer zielgerichteter \nTherapieans&#228;tze (Folgeprojekt)","eudractNumber":null,"id":2252,"indications":[{"id":"lym","name":"Lymphome inkl. Morbus Hodgkin, Multiples Myelom und Chronisch Lymphatischer Leukämie (CLL)"},{"id":"lym1","name":"Plasmozytom (Multiples Myelom)"},{"id":"lym3","name":"Non-Hodgkin Lymphome (inkl. Chron. Lymphat. Leukämie, CLL)"},{"id":"lym4","name":"Weitere"}],"mutations":[],"nctNumber":null,"phase":null,"recruitmentStart":"2013-04-21T11:13:57+02:00","shortTitle":"Charakterisierung des onkogenen Signalnetzwerkes im Multiplen Myelom: Entwicklung neuer zielgerichteter Therapieansätze (Folgeprojekt)","therapeutical":false,"therapyLines":[]},{"active":true,"description":"Evaluierung der adjuvanten Therapie beim Dickdarmkrebs im Stadium II nach ctDNA-Bestimmung","eudractNumber":"2018-003691-12","id":5573,"indications":[{"id":"giu","name":"Bösartige Erkrankungen des unteren Verdauungstraktes (Darm, Leber/Gallenblase, Pankreas)"},{"id":"giu1","name":"Karzinome des Dünn- und Dickdarms (Kolon, Rektum, Anus)"},{"id":"lym","name":"Lymphome inkl. Morbus Hodgkin, Multiples Myelom und Chronisch Lymphatischer Leukämie (CLL)"},{"id":"lym4","name":"Weitere"}],"mutations":[{"name":"MSI (Mikrosatelitteninstabilität)","id":"mt_51"},{"name":"MSI-H","id":"mt_52"},{"name":"Mismatch Repair Deficiency (dMMR)","id":"mt_270"}],"nctNumber":"NCT04089631","phase":{"id":"ph_9","name":"Phase III"},"recruitmentStart":"2020-08-07T08:25:33+02:00","shortTitle":"Circulate AIO-KRK-0217","therapeutical":true,"therapyLines":[{"id":"tl_1","name":"Erstlinie"}]},{"active":true,"description":"<div>COLOPREDICT PLUS 2.0 Register</div><div>Retro- und prospektive Erfassung der Rolle von MSI und KRAS f&#252;r die Prognose beim Kolonkarzinom im Stadium I + II + III</div><div><br /></div><div>DRKS00004305 (keine weiteren Registriernummern)</div>","eudractNumber":null,"id":9356,"indications":[{"id":"giu","name":"Bösartige Erkrankungen des unteren Verdauungstraktes (Darm, Leber/Gallenblase, Pankreas)"},{"id":"giu1","name":"Karzinome des Dünn- und Dickdarms (Kolon, Rektum, Anus)"},{"id":"lym","name":"Lymphome inkl. Morbus Hodgkin, Multiples Myelom und Chronisch Lymphatischer Leukämie (CLL)"},{"id":"lym4","name":"Weitere"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_12","name":"N/A"},"recruitmentStart":"2023-08-31T10:12:47+02:00","shortTitle":"ColoPredict Plus 2.0 Register","therapeutical":false,"therapyLines":[{"id":"tl_6","name":"Adjuvant"}]},{"active":true,"description":"<div>COLOPREDICT PLUS 2.0 Register</div><div>Retro- und prospektive Erfassung der Rolle von MSI und KRAS f&#252;r die Prognose beim Kolonkarzinom im Stadium I + II + III</div><div><br /></div><div>DRKS00004305 (keine weiteren Registriernummern)<br /></div>","eudractNumber":null,"id":4652,"indications":[{"id":"giu","name":"Bösartige Erkrankungen des unteren Verdauungstraktes (Darm, Leber/Gallenblase, Pankreas)"},{"id":"giu1","name":"Karzinome des Dünn- und Dickdarms (Kolon, Rektum, Anus)"},{"id":"lym","name":"Lymphome inkl. Morbus Hodgkin, Multiples Myelom und Chronisch Lymphatischer Leukämie (CLL)"},{"id":"lym4","name":"Weitere"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_12","name":"N/A"},"recruitmentStart":"2021-06-19T14:47:34+02:00","shortTitle":"ColoPredict Plus 2.0 Register","therapeutical":false,"therapyLines":[]},{"active":true,"description":"<div>COLOPREDICT PLUS 2.0 Register</div><div>Retro- und prospektive Erfassung der Rolle von MSI und KRAS f&#252;r die Prognose beim Kolonkarzinom im Stadium I + II + III</div><div><br /></div><div>DRKS00004305 (keine weiteren Registriernummern)</div>","eudractNumber":null,"id":3456,"indications":[{"id":"giu","name":"Bösartige Erkrankungen des unteren Verdauungstraktes (Darm, Leber/Gallenblase, Pankreas)"},{"id":"giu1","name":"Karzinome des Dünn- und Dickdarms (Kolon, Rektum, Anus)"},{"id":"lym","name":"Lymphome inkl. Morbus Hodgkin, Multiples Myelom und Chronisch Lymphatischer Leukämie (CLL)"},{"id":"lym4","name":"Weitere"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_12","name":"N/A"},"recruitmentStart":"2016-11-15T09:30:26+01:00","shortTitle":"ColoPredict Plus 2.0 Register","therapeutical":false,"therapyLines":[]},{"active":true,"description":"Ein Register f&#252;r Befunde und Videos von Endoskopien in der Gastroenterologie","eudractNumber":null,"id":11473,"indications":[{"id":"giu","name":"Bösartige Erkrankungen des unteren Verdauungstraktes (Darm, Leber/Gallenblase, Pankreas)"},{"id":"giu1","name":"Karzinome des Dünn- und Dickdarms (Kolon, Rektum, Anus)"},{"id":"lym","name":"Lymphome inkl. Morbus Hodgkin, Multiples Myelom und Chronisch Lymphatischer Leukämie (CLL)"},{"id":"lym4","name":"Weitere"}],"mutations":[],"nctNumber":"NCT06920680","phase":{"id":"ph_2","name":"Anwendungsbeobachtung"},"recruitmentStart":"2024-07-25T09:29:41+02:00","shortTitle":"ColoReg","therapeutical":false,"therapyLines":[]},{"active":true,"description":"Postoperative Betreuung von Patienten mit tiefem anterioren Resektionssyndrom (LARS) nach operativer Behandlung des Rektumkarzinoms.<div><br /></div><div>DRKS00033615</div>","eudractNumber":null,"id":10726,"indications":[{"id":"giu","name":"Bösartige Erkrankungen des unteren Verdauungstraktes (Darm, Leber/Gallenblase, Pankreas)"},{"id":"giu1","name":"Karzinome des Dünn- und Dickdarms (Kolon, Rektum, Anus)"},{"id":"lym","name":"Lymphome inkl. Morbus Hodgkin, Multiples Myelom und Chronisch Lymphatischer Leukämie (CLL)"},{"id":"lym4","name":"Weitere"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_13","name":"Therapieoptimierung"},"recruitmentStart":"2024-07-01T10:20:30+02:00","shortTitle":"Coloplast/LARS Studie","therapeutical":false,"therapyLines":[]}]}